Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
2(13%)
Results Posted
25%(2 trials)
Terminated
1(6%)

Phase Distribution

Ph not_applicable
3
19%
Ph phase_1
2
13%
Ph phase_2
2
13%
Ph phase_3
1
6%
Ph phase_4
2
13%

Phase Distribution

2

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
2(20.0%)
Phase 2Efficacy & side effects
2(20.0%)
Phase 3Large-scale testing
1(10.0%)
Phase 4Post-market surveillance
2(20.0%)
N/ANon-phased studies
3(30.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

2

trials recruiting

Total Trials

16

all time

Status Distribution
Active(3)
Completed(8)
Terminated(1)
Other(4)

Detailed Status

Completed8
unknown4
Recruiting2
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
2
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (20.0%)
Phase 22 (20.0%)
Phase 31 (10.0%)
Phase 42 (20.0%)
N/A3 (30.0%)

Trials by Status

unknown425%
recruiting213%
completed850%
not_yet_recruiting16%
terminated16%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT06926062Not Applicable

Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial

Not Yet Recruiting
NCT06199934

Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data

Completed
NCT05938192

Multimodality Treatments of HPV-related Lesions of the Female Genital Tract

Recruiting
NCT06686992Not Applicable

The Effect of Distraction Method on Children's Pain and Fear Levels During Vaccine Administration

Completed
NCT04814446Phase 3

Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts

Recruiting
NCT05356312

Glioblastoma and Individualized Therapies

Unknown
NCT03373656Not Applicable

Vaccination for Children of H&O and Their Parents

Unknown
NCT05198453

Impact of Vaccination in Acute COVID-19

Completed
NCT04920357

Immune Response to Vaccination Against Covid-19, a Follow up Study

Unknown
NCT03296423Phase 4

Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly

Completed
NCT01042366Phase 2

Dendritic Cells (DC) Vaccine for Metastatic Melanoma

Terminated
NCT02477254

Long-term Immunogenicity of a HPV Vaccine in SLE

Completed
NCT01571466Phase 1

A Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAART

Completed
NCT01267578Phase 2

Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II)

Unknown
NCT00287677Phase 4

Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected Patients

Completed
NCT00197301Phase 1

Liposomal Based Intranasal Influenza Vaccine:Safety and Efficacy

Completed

All 16 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
16